Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey.
Cheng
Z
Z
Department of Veterinary Pharmacology, University of Glasgow Veterinary School, UK.
McKellar
Q A
QA
Nolan
A
A
Lees
P
P
D000704:Analysis of Variance; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D019540:Area Under Curve; D002351:Carrageenan / Q000008:administration & dosage / Q000633:toxicity; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D018592:Cross-Over Studies; D015194:Diffusion Chambers, Culture; D015232:Dinoprostone / Q000037:antagonists & inhibitors; D018397:Equidae / Q000378:metabolism*; D005079:Excipients / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D006207:Half-Life; D007275:Injections, Intravenous / Q000662:veterinary; D007958:Leukocyte Count / Q000187:drug effects / Q000662:veterinary; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D010653:Phenylbutazone / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D011863:Radioimmunoassay / Q000662:veterinary; D013929:Thromboxane B2 / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005079:Excipients; D013929:Thromboxane B2; D002351:Carrageenan; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D015232:Dinoprostone